EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Reply: Unraveling the Hypocalcemic Response to 177 Lu-Prostate-Specific Membrane Antigen Therapy

Shejil Kumar, Megan Crumbaker, Louise Emmett

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.123.266768 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Shejil Kumar und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms, Castration-Resistant. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

REPLY: We have reviewed the letter to the editor entitled, “Unraveling the Hypocalcemic Response to 177Lu-Prostate-Specific Membrane Antigen Therapy,” which refers to our published article, “The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to 177Lu-Prostate-

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstateProstatic Neoplasms, Castration-ResistantMaleHumansProstate-Specific AntigenLutetiumDipeptidesHeterocyclic Compounds, 1-Ring

Substanzen

Prostate-Specific AntigenLutetiumDipeptidesHeterocyclic Compounds, 1-Ring

Zitieren

APA

Kumar, S., Crumbaker, M., & Emmett, L. (2024). Reply: Unraveling the Hypocalcemic Response to 177 Lu-Prostate-Specific Membrane Antigen Therapy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266768

Vancouver

Kumar S, Crumbaker M, Emmett L. Reply: Unraveling the Hypocalcemic Response to 177 Lu-Prostate-Specific Membrane Antigen Therapy. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266768

BibTeX
@article{Kumar2024,
  author = {Kumar, Shejil and Crumbaker, Megan and Emmett, Louise},
  title = {Reply: Unraveling the Hypocalcemic Response to 177 Lu-Prostate-Specific Membrane Antigen Therapy},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.123.266768}
}
Kostenlos starten →